| |
patient 1 |
patient 2 |
patient 3 |
patient 4 |
age at onset (mo.) |
35 |
21 |
34 |
9 |
seizure type |
M, MA, TC, T, A |
M, DA, T |
M, DA, T, A, CPS |
M, DA |
seizure frequency |
multiple per day |
multiple per day |
multiple per day |
multiple per day |
age at remission (mo.) |
43 |
23 |
42 |
24 |
epilepsy duration (mo.) |
8 |
3 |
8 |
3 |
febrile convulsion |
- |
+ |
- |
- |
family history of epilepsy |
+ |
- |
- |
- |
EEG findings |
SBA
SW, PSW, MF |
SBA
FS, SW |
SBA
PSW, SW |
SBA
FS, SW |
treatment |
VPA, ESM, ZNS, CLB, PHT |
VPA, CZP, ZNS |
CBZ, VPA, ESM, LTG |
VPA |
effective drug(s) |
PHT, ESM, CLB |
VPA, CZP |
VPA, LTG |
VPA |
follow-up period (years) |
10 |
12 |
4 |
5 |
A, absence seizure; CBZ, carbamazepine; CLB, clobazam; CPS, complex partial seizure; CZP, clonazepam; DA, drop attack; ESM, ethosuximide; FS, focal spikes; LTG, lamotrigine; M, myoclonic seizure; MA, myoclonic-astatic seizure; MF, multifocal spikes; PHT, phenytoin; PSW, diffuse polyspike and wave complexes; SBA, slowing of background activity consisting mainly of theta rhythm; SW, diffuse spike and wave complexes T, tonic seizure; TC: tonic-clonic seizure; VPA, valproic acid; ZNS, zonisamide |